My request for some examples has been vindicated. The Minister has been very helpful and it is easier to grapple with specific examples. On the innovation point, let us assume that two pharmaceutical companies want to merge. There will often be a critical mass argument to have the research and development focused on a new product or a combination of two existing products, but at what point is the balance struck between the domination—we do not have a dominance test, sadly—of the market by the new company and its one very successful product? Again, that is a difficult example to conjure with, but it is important that we understand the way in which the Under-Secretary's mind works. How strong will the innovation argument within this exception clause be in such a context?